FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

1568041000168105: ACT Reportable Schedule 4 medications reference set (foundation metadata concept)


Status: current, Primitive. Date: 30-Sep 2021. Module: Third party reference set module

Descriptions:

Id Description Lang Type Status Case? Module
4613741000168115 ACT Reportable Schedule 4 medications reference set (foundation metadata concept) en Fully specified name Active Case sensitive Third party reference set module
4613751000168118 ACT Reportable Schedule 4 medications reference set en Synonym Active Case sensitive Third party reference set module
4613761000168116 ACT Canberra Script Schedule 4 medications reference set en Synonym Active Case sensitive Third party reference set module
4613771000168110 <p>Supports the identification of the Australian Medicines Terminology (AMT) Trade Product Unit of Use (TPUU), Containered Trade Product Pack (CTPP), Medicinal Product Pack (MPP) and Medicinal Product Unit of Use (MPUU) concepts associated with Schedule 4 medicines that are monitored by ACT Health Canberra Script Real-Time Prescription Monitoring (RTPM) solution. </p><p>This reference set can be used by applications to identify Schedule 4 medicines that are to be monitored in support of the ACT Health Canberra Script system’s requirements. The reference set includes medicines registered on the Australian Register of Therapeutic Goods, which contain the following active ingredients: </p><ul><li>Codeine </li><li>Gabapentin </li><li>Pregabalin </li><li>Quetiapine </li><li>Tramadol </li><li>Zolpidem </li><li>Zopiclone </li></ul><p>Benzodiazepines: </p><ul><li>Bromazepam </li><li>Chlordiazepoxide </li><li>Clobazam </li><li>Clonazepam </li><li>Clorazepate </li><li>Diazepam </li><li>Flurazepam </li><li>Ketazolam </li><li>Loprazolam </li><li>Lorazepam </li><li>Lormetazepam </li><li>Medazepam </li><li>Midazolam </li><li>Motrazepam </li><li>Nitrazepam </li><li>Oxazepam </li><li>Prazepam </li><li>Quazepam </li><li>Temazepam </li><li>Triazolam </li><li>Zolazepam </li></ul><p><b>Target client: </b>This reference set was developed by the National Clinical Terminology Service for, and in collaboration with, ACT Health, to support the Canberra Script Real Time Prescription Monitoring solution. It may be used by developers to meet the requirements of the Canberra Script solution.</p><p><b>Labels:</b> RTPM, RTR, S4</p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p> en Definition Active Case sensitive Third party reference set module


6598 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
ACT Reportable Schedule 4 medications reference set Is a Reference sets for Medications true Inferred relationship Some
ACT Reportable Schedule 4 medications reference set Is a Simple type reference set true Inferred relationship Some
ACT Reportable Schedule 4 medications reference set Developed by ACT Health true Inferred relationship Some 553705380

Members
Lyzalon 75 mg capsule, 56, bottle
Lyzalon 75 mg capsule, 60, blister pack
Lyzalon 75 mg capsule, 60, bottle
Lyzalon 75 mg capsule, 84, blister pack
Maxydol tablet
Maxydol tablet, 20, blister pack
Maxydol tablet, 40, blister pack
Mersyndol tablet
Mersyndol tablet, 20, blister pack
Mersyndol tablet, 40, blister pack
Mersyndol Caplet tablet
Mersyndol Caplet tablet, 2, blister pack
Mersyndol Caplet tablet, 20, blister pack
Mersyndol Caplet tablet, 40, blister pack
Mersyndol Daystrength tablet
Mersyndol Daystrength tablet, 12, blister pack
Mersyndol Daystrength tablet, 2, blister pack
Mersyndol Daystrength tablet, 24, blister pack
Mersyndol Daystrength tablet, 36, blister pack
Mersyndol Daystrength tablet, 40, blister pack
Mersyndol Daystrength tablet, 48, blister pack
Mersyndol Forte tablet
Mersyndol Forte tablet, 10, blister pack
Mersyndol Forte tablet, 2, blister pack
Mersyndol Forte tablet, 20, blister pack
Mersyndol Forte tablet, 40, blister pack
Mevadol Forte tablet
Mevadol Forte tablet, 20, blister pack
Midalim 15 mg/3 mL injection, 3 mL ampoule
Midalim 15 mg/3 mL injection, 10 x 3 mL ampoules
Midalim 15 mg/3 mL injection, 3 mL ampoule
Midalim 15 mg/3 mL injection, 5 x 3 mL ampoules
Midalim 5 mg/mL injection, ampoule
Midalim 5 mg/mL injection, 1 mL ampoule
Midalim 5 mg/mL injection, 10 x 1 mL ampoules
Midalim 5 mg/mL injection, 5 x 1 mL ampoules
Midalim (midazolam 5 mg / 5 mL) injection, 1 x 5 mL ampoule (containered trade product pack)
Midalim 5 mg/5 mL injection, 10 x 5 mL ampoules
Midalim 5 mg/5 mL injection, 5 mL ampoule
Midalim 5 mg/5 mL injection, 5 x 5 mL ampoules
Midalim (midazolam 50 mg / 10 mL) injection, 1 x 10 mL ampoule (containered trade product pack)
Midalim 50 mg/10 mL injection, 10 mL ampoule
Midalim 50 mg/10 mL injection, 10 x 10 mL ampoules
Midalim 50 mg/10 mL injection, 5 x 10 mL ampoules
Midavel 15 mg/3 mL injection, 3 mL ampoule
Midavel 15 mg/3 mL injection, 10 x 3 mL ampoules
Midavel 15 mg/3 mL injection, 3 mL ampoule
Midavel 15 mg/3 mL injection, 5 x 3 mL ampoules
Midavel 5 mg/mL injection, ampoule
Midavel 5 mg/mL injection, 1 mL ampoule
Midavel 5 mg/mL injection, 10 x 1 mL ampoules
Midavel (midazolam 5 mg / 1 mL) injection, 5 x 1 mL ampoules (containered trade product pack)
Midavel 5 mg/5 mL injection, 5 mL ampoule
Midavel 5 mg/5 mL injection, 10 x 5 mL ampoules
Midavel 5 mg/5 mL injection, 5 mL ampoule
Midavel 5 mg/5 mL injection, 5 x 5 mL ampoules
Midavel 50 mg/10 mL injection, 10 mL ampoule
Midavel 50 mg/10 mL injection, 10 mL ampoule
Midavel 50 mg/10 mL injection, 10 x 10 mL ampoules
Midavel 50 mg/10 mL injection, 5 x 10 mL ampoules
Midazolam (AN) 15 mg/3 mL injection, 3 mL ampoule
Midazolam (AN) 15 mg/3 mL injection, 10 x 3 mL ampoules
Midazolam (AN) 15 mg/3 mL injection, 3 mL ampoule
Midazolam (AN) 15 mg/3 mL injection, 5 x 3 mL ampoules
Midazolam (AN) 5 mg/mL injection, ampoule
Midazolam (AN) 5 mg/mL injection, 1 mL ampoule
Midazolam (AN) 5 mg/mL injection, 10 x 1 mL ampoules
Midazolam (AN) 5 mg/mL injection, 5 x 1 mL ampoules
Midazolam (AN) 5 mg/5 mL injection, 5 mL ampoule
Midazolam (AN) 5 mg/5 mL injection, 10 x 5 mL ampoules
Midazolam (AN) 5 mg/5 mL injection, 5 mL ampoule
Midazolam (AN) 5 mg/5 mL injection, 5 x 5 mL ampoules
Midazolam (AN) 50 mg/10 mL injection, 10 mL ampoule
Midazolam (AN) 50 mg/10 mL injection, 10 mL ampoule
Midazolam (AN) 50 mg/10 mL injection, 10 x 10 mL ampoules
Midazolam (AN) 50 mg/10 mL injection, 5 x 10 mL ampoules
Midazolam (Accord) 15 mg/3 mL injection, 3 mL ampoule
Midazolam (Accord) 15 mg/3 mL injection, 10 x 3 mL ampoules
Midazolam (Accord) 15 mg/3 mL injection, 3 mL ampoule
Midazolam (Accord) 15 mg/3 mL injection, 5 x 3 mL ampoules
Midazolam (Accord) 5 mg/mL injection, ampoule
Midazolam (Accord) 5 mg/mL injection, 1 mL ampoule
Midazolam (Accord) 5 mg/mL injection, 10 x 1 mL ampoules
Midazolam (Accord) 5 mg/mL injection, 5 x 1 mL ampoules
Midazolam (Accord) 5 mg/5 mL injection, 5 mL ampoule
Midazolam (Accord) 5 mg/5 mL injection, 1 x 5 mL syringe
Midazolam (Accord) 5 mg/5 mL injection, 10 x 5 mL ampoules
Midazolam (Accord) 5 mg/5 mL injection, 5 mL ampoule
Midazolam (Accord) 5 mg/5 mL injection, 5 mL syringe
Midazolam (Accord) 5 mg/5 mL injection, 5 x 5 mL ampoules
Midazolam (Accord) 50 mg/10 mL injection, 10 mL ampoule
Midazolam (Accord) 50 mg/10 mL injection, 1 x 10 mL syringe
Midazolam (Accord) 50 mg/10 mL injection, 10 mL ampoule
Midazolam (Accord) 50 mg/10 mL injection, 10 mL syringe
Midazolam (Accord) 50 mg/10 mL injection, 10 x 10 mL ampoules
Midazolam (Accord) 50 mg/10 mL injection, 5 x 10 mL ampoules
Midazolam (Act) 15 mg/3 mL injection, 3 mL ampoule
Midazolam (Act) 15 mg/3 mL injection, 10 x 3 mL ampoules
Midazolam (Act) 15 mg/3 mL injection, 3 mL ampoule
Midazolam (Act) (midazolam 15 mg / 3 mL) injection, 5 x 3 mL ampoules (containered trade product pack)
Midazolam (Act) 5 mg/mL injection, ampoule

Start Previous Page 21 of 66 Next End


Reference Sets

Reference set descriptor

Back to Start